Instituto de Investigación Biomédica de A Coruña (INIBIC)
Centro de investigación
José Manuel
García Pinilla
Publicacións nas que colabora con José Manuel García Pinilla (52)
2024
-
Heart failure in Europe: Guideline-directed medical therapy use and decision making in chronic and acute, pre-existing and de novo, heart failure with reduced, mildly reduced, and preserved ejection fraction – the ESC EORP Heart Failure III Registry
European Journal of Heart Failure
-
Penetrance of Dilated Cardiomyopathy in Genotype-Positive Relatives
Journal of the American College of Cardiology, Vol. 83, Núm. 17, pp. 1640-1651
-
Repetitive ambulatory levosimendan as a bridge to heart transplantation
Revista Espanola de Cardiologia, Vol. 77, Núm. 4, pp. 290-301
-
Role of TBX20 Truncating Variants in Dilated Cardiomyopathy and Left Ventricular Noncompaction
Circulation: Genomic and Precision Medicine, Vol. 17, Núm. 2, pp. E004404
-
Vaccine–carditis study: Spanish multicenter registry of inflammatory heart disease after COVID-19 vaccination
Clinical Research in Cardiology, Vol. 113, Núm. 2, pp. 223-234
2023
-
Association between common cardiovascular risk factors and clinical phenotype in patients with hypertrophic cardiomyopathy from the European Society of Cardiology (ESC) EurObservational Research Programme (EORP) Cardiomyopathy/Myocarditis registry
European Heart Journal - Quality of Care and Clinical Outcomes, Vol. 9, Núm. 1, pp. 42-53
-
Heart failure risk scores in advanced heart failure patients: insights from the LEVO-D registry
ESC Heart Failure, Vol. 10, Núm. 5, pp. 2875-2881
-
Intermittent inotropic support with levosimendan in advanced heart failure as destination therapy: The LEVO-D registry
ESC Heart Failure, Vol. 10, Núm. 2, pp. 1193-1204
-
Rationale and design of the ESC Heart Failure III Registry – Implementation and discovery
European Journal of Heart Failure, Vol. 25, Núm. 12, pp. 2316-2330
2022
-
Characterization of hereditary transthyretin cardiac amyloidosis in Spain
Revista Espanola de Cardiologia, Vol. 75, Núm. 6, pp. 488-495
-
Clinical Risk Score to Predict Pathogenic Genotypes in Patients With Dilated Cardiomyopathy
Journal of the American College of Cardiology, Vol. 80, Núm. 12, pp. 1115-1126
-
Combination of late gadolinium enhancement and genotype improves prediction of prognosis in non-ischaemic dilated cardiomyopathy
European Journal of Heart Failure, Vol. 24, Núm. 7, pp. 1183-1196
-
Erratum: Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator (European Heart Journal (2022) (ehac235) DOI: 10.1093/eurheartj/ehac235)
European Heart Journal
-
Frailty and prognosis of older patients with chronic heart failure
Revista Espanola de Cardiologia, Vol. 75, Núm. 12, pp. 1011-1019
-
Impact of SARS-Cov-2 infection in patients with hypertrophic cardiomyopathy: results of an international multicentre registry
ESC Heart Failure, Vol. 9, Núm. 4, pp. 2189-2198
-
Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator
European heart journal, Vol. 43, Núm. 32, pp. 3053-3067
-
Key factors for optimal care models for heart failure. An integrative and multidisciplinary approach
REC: CardioClinics, Vol. 57, Núm. 1, pp. 24-38
-
Natural History of MYH7-Related Dilated Cardiomyopathy
Journal of the American College of Cardiology, Vol. 80, Núm. 15, pp. 1447-1461
-
Prevalence, Incidence, and Outcomes of Hyperkalaemia in Patients with Chronic Heart Failure and Reduced Ejection Fraction from a Spanish Multicentre Study: SPANIK-HF Design and Baseline Characteristics
Journal of Clinical Medicine, Vol. 11, Núm. 5
-
Recommendations to develop Care Models for patients with Heart Failure (MAIC Project) from macromanagement
Journal of Healthcare Quality Research, Vol. 37, Núm. 2, pp. 100-109